Research/Studies

Nexalin Announces Peer-Reviewed Publication with Neuroimagina Data in Psychotherapy and Psychosomatics Hiahliahting Brain-Network Effects and Clinical Improvement in Chronic Insomnia
Insomnia Research/Studies

Nexalin Study Shows Brain-Network Changes and Sleep Improvement in Chronic Insomnia

Nexalin Technology, Inc. announced the online publication of a peer-reviewed study in Psychotherapy and Psychosomatics reporting significant clinical improvement and measurable brain-network modulation in patients with chronic insomnia treated with the Company’s high-power 15 mA, 77.5 Hz stimulation approach. The paper was published online on April 20, 2026.  The study, titled: “Modulating […]

Alkermes Announces Phase 3 Brilliance Studies Evaluating Alixorexton for Narcolepsy Type 1 and Type 2
Narcolepsy Research/Studies Sleep Pharmaceuticals

Alkermes Announces Phase 3 Brilliance Studies Evaluating Alixorexton for Narcolepsy Type 1 and Type 2

Alkermes plc, announced the initiation of the Brilliance Studies, a phase 3 program evaluating the safety and efficacy of alixorexton compared to placebo in adults with narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2). Alixorexton is the company’s novel, investigational, oral, selective orexin 2 receptor (OX2R) agonist in development […]

Researchers’ Sweat-Based Sensor May Help Improve Sleep Quality
Research/Studies

Researchers’ Sweat-Based Sensor May Help Improve Sleep Quality

University of Texas at Dallas researchers, in partnership with Texas-based biotech company EnLiSense, have demonstrated a pioneering wearable perspiration-based sensor that measures two key hormones that regulate the body’s sleep-wake cycle. The electrochemical sensor continuously monitors cortisol, which promotes wakefulness, and melatonin, which signals the body to sleep. The bioengineers […]

Nexalin Announces Pivotal HALO Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market
Industry News Insomnia Research/Studies

Nexalin’s HALO Clarity Trial to Support Planned De Novo FDA Submission Targeting Insomnia Market

Nexalin Technology, Inc. announced continued advancement toward its planned pivotal clinical trial evaluating HALO™ Clarity for the treatment of moderate to severe insomnia, designed to support Nexalin’s planned de novo submission to the U.S. Food and Drug Administration. The study is being conducted in collaboration with Lindus Health, a full-service clinical […]

Sleep to Overnight Clearing of Alzheimer's-Linked Proteins
Research/Studies

Study Links Sleep to Overnight Clearing of Alzheimer’s-Linked Proteins

What if sleep could help prevent Alzheimer’s disease? A new landmark study by researchers at Applied Cognition, a clinical-stage therapeutic company, points to the brain’s glymphatic system, its fluid-based “clean-up” pathway, as a key driver of overnight clearance of Alzheimer’s-linked proteins. The researchers found that during normal sleep, levels of amyloid beta and […]